GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
126.48
3.60 (2.93%)
At close: Aug 15, 2025, 3:12 PM
Company Description
GeneDx Holdings Corp. is a patient centered health intelligence company.
It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories.
The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs.
The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
GeneDx Corp.
| Country | United States |
| IPO Date | Nov 4, 2020 |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Employees | 1,000 |
| CEO | Katherine A. Stueland |
Contact Details
Address: North Tower Stamford, Connecticut United States | |
| Website | http://www.genedx.com |
Stock Details
| Ticker Symbol | WGS |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001818331 |
| CUSIP Number | 81663L200 |
| ISIN Number | US81663L2007 |
| Employer ID | 85-1966622 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Katherine A. Stueland | President, Chief Executive Officer & Director |
| Dr. Bryan M. Dechairo Ph.D. | Chief Operating Officer |
| Heidi C. Chen J.D. | Chief Legal Officer |
| Kevin Feeley CPA | Chief Financial Officer |
| Dr. Martin G. Reese Ph.D. | President of Fabric Genomics |
| Jami Biliboaca | Head of People Strategy |
| Melanie Duquette | Chief Growth Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Aug 07, 2025 | 4/A | [Amend] Filing |
| Aug 06, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Jul 31, 2025 | 4 | Filing |
| Jul 31, 2025 | 4 | Filing |
| Jul 30, 2025 | SCHEDULE 13G | Filing |
| Jul 29, 2025 | 10-Q | Quarterly Report |
| Jul 29, 2025 | 8-K | Current Report |
| Jul 11, 2025 | 4 | Filing |
| Jul 11, 2025 | 4 | Filing |